Annual Breakthrough of the Year from the journal Science.
Focus is on the drug that is called Ozempic when prescribed for diabetes and Wegovy when prescribed for obesity, but other past and upcoming drugs described too.
Was surprised by this award since there are still so many unknowns, with studies showing both positive and negative effects.
One remarkable stat: "1.7% of people in the U.S. have been prescribed either Wegovy or Ozempic this year."
Links:
Article
Video
Focus is on the drug that is called Ozempic when prescribed for diabetes and Wegovy when prescribed for obesity, but other past and upcoming drugs described too.
Was surprised by this award since there are still so many unknowns, with studies showing both positive and negative effects.
One remarkable stat: "1.7% of people in the U.S. have been prescribed either Wegovy or Ozempic this year."
Links:
Article
Video